1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > PharmaPoint: Schizophrenia - Current and Future Players

PharmaPoint: Schizophrenia - Current and Future Players

  • February 2014
  • -
  • Global Data
  • -
  • 40 pages

PharmaPoint: Schizophrenia - Current and Future Players

Summary

GlobalData has released its pharma report, “PharmaPoint: Schizophrenia - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Schizophrenia Market. The report identifies and analyses the key companies shaping and driving the global Schizophrenia market. The report provides insight into the competitive Schizophrenia landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData’s team of industry experts.

Scope

- Investigation of current and future market competition for Schizophrenia
- Competitor assessment
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of the Schizophrenia sector through market impact analysis, future market scenario and company analysis

Reasons to buy

- Gain a high level view of the trends shaping and driving the Schizophrenia Market
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- What’s the next big thing in the global Schizophrenia market landscape? Identify, understand and capitalize

Table Of Contents

PharmaPoint: Schizophrenia - Current and Future Players
1 Table of Contents

2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 10
2.3 Upcoming Reports 11
3 Market Outlook 12
3.1 Global Markets 12
3.1.1 Forecast 12
3.1.2 Global Drivers and Barriers 16
4 Current and Future Players 18
4.1 Overview 18
4.2 Trends in Corporate Strategy 19
4.3 Company Profiles 19
4.3.1 Janssen Pharmaceuticals 19
4.3.2 Eli Lilly and Company 22
4.3.3 Roche 24
4.3.4 Alkermes 26
4.3.5 EnVivo Pharmaceuticals 28
5 Appendix 30
5.1 Bibliography 30
5.2 Abbreviations 31
5.3 Methodology 33
5.4 Forecasting Methodology 33
5.4.1 Diagnosis and Treatment Rates 33
5.4.2 Adherence Rates 34
5.4.3 General Pricing Assumptions 34
5.4.4 Generic Erosion 35
5.5 Key Opinion Leaders 36
5.6 About the Authors 37
5.6.1 Author 37
5.6.2 Reviewers 37
5.6.3 Global Head of Healthcare 38
5.7 About GlobalData 39
5.8 Disclaimer 39

1.1 List of Tables

Table 1: Global Sales Forecast ($m) for Schizophrenia, 2012-2022 14
Table 2: Global Schizophrenia Market, Drivers and Barriers, 2012-2022 16
Table 3: Janssen Schizophrenia Portfolio Assessment, 2014 21
Table 4: Janssen SWOT Analysis, 2014 22
Table 5: Eli Lilly Schizophrenia Portfolio Assessment, 2014 24
Table 6: Eli Lilly SWOT Analysis, 2014 24
Table 7: Roche Schizophrenia Portfolio Assessment, 2014 25
Table 8: Roche SWOT Analysis, 2014 26
Table 9: Alkermes Schizophrenia Portfolio Assessment, 2014 27
Table 10: Alkermes SWOT Analysis, 2014 27
Table 11: EnVivo Schizophrenia Portfolio Assessment, 2014 28
Table 12: EnVivo Pharmaceuticals SWOT Analysis, 2014 29

1.2 List of Figures

Figure 1: Global Schizophrenia Drug Sales by Region, 2012-2022 15
Figure 2: Schizophrenia Therapeutics - Pipeline by Company, 2014 18

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Alcoholism and drug dependence and addiction, known as substance use disorders and rehabilitation treatments are classified as substance abuse treatment. Some of the common symptoms of drug abuse are ...

Epiomic Epidemiology Series: Traumatic Brain Injury Forecast in 21 Major Markets 2016-2026

Epiomic Epidemiology Series: Traumatic Brain Injury Forecast in 21 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • October 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Traumatic Brain Injury in 21 Major Markets Traumatic brain injury (TBI) or acquired brain injury is a non-specific term describing ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.